Moreover, HRD scores may not fully capture the context in which PARP1 and PARP2 protect the CRC genome against worsening genotoxic stress, nor the contexts in which their inhibition would be beneficial for tumor cell killing [8]. The gene discussed is PARP2; the disease is neoplasm.